• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
academic & health care centers

Sickle Cell Disease Program at Children’s Health

1935 Medical District Dr.
Dallas, Texas, United States
Phone   Web  

The Sickle Cell Disease Program at Children’s is one of the nation’s largest serving pediatric patients. It focuses on the prevention of disease complications and management using the newest treatment strategies, including hydroxyurea, chronic transfusions, stem cell (bone marrow) transplantation and state-of-the-art approaches to infection prevention, pain management and treatment of specific organ-related complications (chest syndrome, priapism, avascular necrosis of the femoral head, etc.).

Children’s Health offers standard treatment modalities, such as chronic blood transfusion programs, hydroxyurea therapy and stem cell transplantation. We are also studying molecular targeted treatment for pain control in sickle cell disease.

Hematologists on the medical staff at Children’s have spearheaded the development of a comprehensive set of diagnostic and management guidelines for children with sickle cell disease that have been endorsed by the Texas Department of Health.

Sickle cell patient information, such as every hospitalization and major complication, has been collected for 20 years on a computerized database, which helps improve continuity of care and research.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.